Toni Seppälä (@Adductor) header
Toni Seppälä (@Adductor) profile picture

MD, PhD, Professor, GI surgeon, chief physician @TampereUniMET and TAYS. Johns Hopkins alumni. PI @HelsinkiUniMed Applied Tumor Genomics and HUS

Tampere, Finland
Joined November 2009
Photo by Toni Seppälä (@Adductor)Photo by Toni Seppälä (@Adductor)Photo by Toni Seppälä (@Adductor)Photo by Toni Seppälä (@Adductor)Photo by Toni Seppälä (@Adductor)Photo by Toni Seppälä (@Adductor)Photo by Toni Seppälä (@Adductor)Photo by Toni Seppälä (@Adductor)Photo by Toni Seppälä (@Adductor)Photo by Toni Seppälä (@Adductor)
European guidelines for #Lynchsyndrome by @EHTG_Tweets and @escp_tweets online (part). See the executive summary available @BJSurgery Thank you @GabrielaMoslein @IonutNegoi @AndyLatchford @mev_dv @ProfEmmaCrosbie @neilajryan @CaPP3 @ASampaioSoares bjssjournals.onlinelibrary.w…
2
26
4
41
🚨 Big step forward in cancer research! The EU has awarded €13.6M to the international PREDI-LYNCH project to boost early detection of Lynch syndrome-related cancers. Tampere University is proud to be one of the key partners in this important initiative. tuni.fi/en/news/eu13-6-milli…
2
6
3
31
1,275
New trial coming up - PROSPERITY trial comparing protective ileostomy versus colostomy in anterior rectal resection. Presented at @escp_tweets. Protocol now out in @BMJ_Open! Trial is open for new centers also! Contact @LauraKoskenvuo if interested! bmjopen.bmj.com/content/bmjo…
2
16
1
43
4,516
🧵1/ 🚨 Just out: the PLSD's biggest prospective study yet on Lynch syndrome & colorectal cancer (CRC) surgery. What’s the real risk of a second CRC—and can surgery prevent it? Spoiler: Prior CRC = higher risk. Extended surgery = game changer. 👇 🔗 doi.org/10.1093/bjs/znaf061
1
8
4
13
1,847
11/ 📣 For clinicians: If LS is confirmed pre-op, discuss: ✅ Risk of metachronous CRC ✅ Surveillance burden ✅ Surgical complications ✅ Functional outcomes 🧬 This is precision surgery — based on real risk.
1
2
3
199
Tutkimusryhmämme rekrytoi *projektipäällikköä* ohjaamaan kliinisiä ja translationaalisia monikeskustutkimuksia. Hae mukaan tiimiin! tuni.rekrytointi.com/paikat/…
2
6
273
Toni Seppälä retweeted
Excited to share our urine tumor DNA assay #UroScout results published today in @EUplatinum 👉 authors.elsevier.com/c/1jzvn… Sensitive Detection of Urothelial Cancer via High-volume Urine DNA Analysis 🧬 497 urine DNA samples from 281 patients ✅100% sens for ≥T1 bladder cancer ✅ 94% sens for Ta bladder cancer ✅ 92% sens for any grade UTUC ✅ 100% sens for MI/HG-UTUC ✅ 90% sens for recurrence detection ✅ Identification of Lynch syndrome 💡 Three-tier diagnostic workflow for cystoscopy pre-screening 👉 Potential to replace ~80% of diagnostic cystoscopies 👉 2 utDNA mutations, AF≥5% ➡️ PPV 100% ➡️ 69% of UC patients could be scheduled directly for OR procedures @TampereUni @Tays_sairaala @VanProstateCtr #MattiAnnala @TVeitonmaki @NykterLab @ResearchWyatt @pcvblack @G_Vandekerkhove @D_C_Muller 🔍 Check supplementaries for more results Link: authors.elsevier.com/c/1jzvn…
4
13
1
50
5,747
presentation of our upcoming PROSPERITY trial at #escp2024 by @LauraKoskenvuo @villesallinen @Adductor
1
4
1
5
7,272
New @TheLancet - Adam et al - Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet trial) thelancet.com/journals/lance… #CRCSM #LiverTwitter
2
113
10
264
44,554
MSc @SievanenTero defended his PhD thesis today @JYUsport_health on ”The associations of circulating microRNAs and lifestyle habits with cancer risk in #Lynchsyndrome ”. The honorable opponent Arto Mannermaa @UniEastFinland, kustos @eija_laakkonen @gerec_fi #Y-EHTG
3
23
678
Toni Seppälä retweeted
Join us at the EHTG Meeting 2024 for a pivotal session on cancer prevention. Don’t miss the opportunity to hear Matthias Kloor as he delves into pioneering immune prevention strategies for Lynch syndrome, revealing how we can utilize the immune system to prevent hereditary cancer
6
11
561